Skip to main content
. 2024 Jul 19;13(7):1585–1594. doi: 10.21037/tlcr-24-128

Figure 1.

Figure 1

PFS and OS in the entire cohort. (A) Kaplan-Meier graph of PFS in the 40 patients with durvalumab plus platinum-etoposide. (B) Kaplan-Meier graph of OS in the 40 patients with durvalumab plus platinum-etoposide. PFS, progression-free survival; CI, confidence interval; OS, overall survival.